Skip to main content

Table 3 Medications used by pregnant women at different trimesters and their US FDA pregnancy risk classification in HFSUH, eastern Ethiopia from September 1, 2016 to August 31, 2017

From: Drug utilization pattern among pregnant women attending maternal and child health clinic of tertiary hospital in eastern Ethiopia: Consideration of toxicological perspectives

Drug name

1st trimester

Frequency

2nd trimester

Frequency

3rd trimester

Frequency

Total

Frequency

FDA risk category

Amoxicillin

3

4

0

7

B

Augmentin

1

0

0

1

B

Azithromycin

4

1

0

5

B

Carbamazepine

2

0

0

2

D

Ceftriaxone

1

0

0

1

B

Cephalexin

1

1

1

3

B

Cimetidine

2

1

2

5

B

Cotrimoxazole

1

0

0

1

D

Chlorpromazine

4

0

0

4

C

Diazepam

1

0

0

1

D

Diclofenac

3

0

0

3

C

Diphenhydramine

0

1

0

1

B

Haloperidol

1

0

0

1

C

Hydrocortisone

1

0

0

1

C

Iron/folatea

313

A

Mebendazole

1

0

0

1

C

Metoclopramide

1

1

0

2

B

Metronidazole

0

1

1

2

B

MTS

1

0

1

2

C

Multi-vitamina

4

1

2

7

A

Omeprazole

1

1

1

3

C

Paracetamol

2

2

0

4

B

Prednisolone

1

0

0

1

D

Salbutamol

1

0

1

2

C

TDF + 3TC + EFV

1

0

0

1

C

Tramadol

1

0

1

2

B

Triple therapy

0

0

1

1

C

Total

39b

14b

11b

64b (377)

 
  1. aSupplemental drug given throughout the pregnancy
  2. bDrugs other than Iron/folate; the number in parenthesis indicates the total number of drugs including iron/folate